Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Charles River Laboratories cooperation agreement with Elliott
We are advising Charles River on the agreement
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Top-Up Placing of Shares in Innovent Biologics, Inc.
Davis Polk advised the placing agents for the top-up placement of up to 97,000,000 shares in Innovent Biologics, Inc. for a…
BioXcel Therapeutics, Inc. $18.9 Million Common Stock Offering
Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 2,303…
McKesson Corporation $4 Billion Revolving Credit Agreement
Davis Polk advised the joint lead arranger and bookrunner, and the administrative agent, in connection with a $4 billion…
AbbVie Inc. €1.4 Billion Senior Notes Offering
Davis Polk advised the underwriters in connection with an SEC-registered offering by AbbVie Inc. of €1.4 billion aggregate…
Tax counsel to Danaher on the separation and IPO of its dental business
Davis Polk is acting as special tax counsel to Danaher Corporation on the separation of its dental division into a new…
PTC Therapeutics, Inc. Concurrent $100 Million Common Stock Offering and $287.5 Million Convertible Senior Notes Offering
Davis Polk advised the underwriter in connection with the SEC-registered offering by PTC Therapeutics, Inc. of 2,475,248…
Heska Corporation $86.25 Million Convertible Senior Notes Offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Heska Corporation of an aggregate…
iRhythm Technologies, Inc. $115 Million Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC…
Turning Point Therapeutics, Inc. $202.5 Million Follow-On Offering
Davis Polk advised the underwriters in connection with a $202.5 million public offering of common stock by Turning Point…
Insulet Corporation Convertible Senior Notes Offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Insulet Corporation of $800 million…